Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
08 March, 2021 11:45 IST
Caplin Point Lab subsidiary in partnership with JAMP Pharma Group
Source: IRIS | 18 Jan, 2021, 12.49PM
Rating: NAN / 5 stars.
Comments  |  Post Comment

 Caplin Point Laboratories announced that its subsidiary Caplin Steriles has entered into a strategic partnership with JAMP Pharma Group for six injectable products to be filed shortly in Canada. Some of these products have already been filed by Caplin Steriles in the USA.

Commenting on the transaction, C C. Paarthipan, Chairman of Caplin Point Laboratories, said, "We have targeted Canada as one of our key expansion areas in Regulated Markets and we are excited to work with ]AMP, one of the fastest growing companies in Canada. We are confident that we will be adding more products to this partnership in due course."

Louis Pilon, JAMP Pharma Group's CEO added, "We are very pleased and excited to enter into this partnership with Caplin Point Laboratories. This partnership will allow us to continue our mission to provide more affordable options to Canadian patients, as well as our retail and institutional partners. We certainly hope to collaborate on more products with our new partner in the coming years."

Caplin Point Laboratories is a fast growing pharmaceutical company with a unique business model, catering predominantly to emerging markets of Latin America and Africa.

Caplin Steriles, a subsidiary of Caplin Point Laboratories, is a niche sterile product manufacturing company that is approved by US FDA and EU-GMP.

 Shares of the company declined Rs 1.5, or 0.31%, to trade at  Rs 485.50.  The total volume of shares traded  was  9,368 at the BSE (11.25 a.m., Monday).



 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Jagran Prakashan plans to buyback shares worth Rs 1,180 mn - 08-Mar-2021 09:27
Kotak Mahindra Bank divests 10% stake in ECA Trading Services to its arm - 08-Mar-2021 09:07
Hero MotoCorp February sales crosses 5 lakh units - 05-Mar-2021 17:57
PVR launches new six-screen property in Mysuru - 05-Mar-2021 16:55
Sangam Renewables commissions 16 MW solar project in Maharashtra - 05-Mar-2021 13:47
Voltas strong performance raises expectations of blockbuster summer sales: Motilal Oswal - 05-Mar-2021 13:27
Unichem Lab gets USFDA nod for Guanfacine Tablets - 05-Mar-2021 13:03
Wipro-Capco acquisition- A Bold Move; REDUCE: IDBI Capital - 05-Mar-2021 11:44
VST Tillers Tractors to invest in Zimeno Inc - 05-Mar-2021 09:36
Welspun India's board approves raising up to USD 100 mn - 05-Mar-2021 09:23
Oswal Yarns board appoints Nipun Vyas as Independent Director - 05-Mar-2021 09:01
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer